The effect of disease site (knee, hip, hand, foot, lower back or neck) on employment reduction due to osteoarthritis.
BACKGROUND
Osteoarthritis (OA) has a significant impact on individuals' ability to work. Our goal was to investigate the effects of the site of OA (knee, hip, hand, foot, lower back or neck) on employment reduction due to OA (EROA).


RESULTS
This study involved a random sample of 6,000 patients with OA selected from the Medical Service Plan database in British Columbia, Canada. A total of 5,491 were alive and had valid addresses, and of these, 2,259 responded (response rate = 41%), from which 2,134 provided usable data. Eligible participants were 19 or older with physician diagnosed OA based on administrative data between 1992 and 2006. Data of 688 residents were used (mean age 62.1 years (27 to 86); 60% women). EROA had three levels: no reduction; reduced hours; and total cessation due to OA. The (log) odds of EROA was regressed on OA sites, adjusting for age, sex, education and comorbidity. Odds ratios (ORs) represented the effect predicting total cessation and reduced hours/total cessation. The strongest effect was found in lower back OA, with OR = 2.08 (95% CI: 1.47, 2.94), followed by neck (OR = 1.59; 95% CI: 1.11, 2.27) and knee (OR = 1.43; 95% CI: 1.02, 2.01). We found an interaction between sex and foot OA (men: OR = 1.94; 95% CI: 1.05, 3.59; women: OR = 0.89; 95% CI = 0.57, 1.39). No significant effect was found for hip OA (OR = 1.33) or hand OA (OR = 1.11). Limitations of this study included a modest response rate, the lack of an OA negative group, the use of administrative databases to identify eligible participants, and the use of patient self-reported data.


CONCLUSIONS
After adjusting for socio-demographic variables, comorbidity, and other OA disease sites, we find that OA of the lower back, neck and knee are significant predictors for EROA. Foot OA is only significantly associated with EROA in males. For multi-site combinations, ORs are multiplicative. These findings may be used to guide resource allocation for future development/improvement of vocational rehabilitation programs for site-specific OA.
Sayre
Eric C
EC
Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada. esayre@arthritisresearch.ca
Li
Linda C
LC
Kopec
Jacek A
JA
Esdaile
John M
JM
Bar
Sherry
S
Cibere
Jolanda
J
D019645:Arthroplasty, Replacement, Knee; D004651:Employment; D005260:Female; D005528:Foot / Q000473:pathology; D006225:Hand / Q000473:pathology; D006615:Hip / Q000473:pathology; D006801:Humans; D007717:Knee / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009333:Neck / Q000473:pathology; D016017:Odds Ratio; D009928:Organ Specificity; D010003:Osteoarthritis / Q000473:pathology*
Foot Ankle Int. 2006 Aug;27(8):606-11
16919213
Occup Environ Med. 2005 Jan;62(1):54-7
15613609
Osteoarthritis Cartilage. 2006 Sep;14(9):953-7
16759885
Rev Chir Orthop Reparatrice Appar Mot. 2006 Apr;92(2):175-92
16800074
Arthritis Rheum. 2008 Dec 15;59(12):1805-13
19035423
Pain. 2004 Jul;110(1-2):361-8
15275787
Arthritis Rheum. 2009 May 15;61(5):605-13
19405013
Arthritis Rheum. 2008 Apr 15;59(4):489-96
18383421
Arthritis Rheum. 2005 Apr;52(4):1077-80
15818669
Prehosp Emerg Care. 2009 Apr-Jun;13(2):256-60
19291567
Rheumatology (Oxford). 2005 Dec;44(12):1531-7
16091394
BMC Musculoskelet Disord. 2007 Sep 18;8:93
17877790
Best Pract Res Clin Rheumatol. 2008 Jun;22(3):435-49
18519098
Occup Environ Med. 2007 Dec;64(12):798-805
17567725
J Am Podiatr Med Assoc. 2005 Nov-Dec;95(6):573-9
16291849
Arthritis Rheum. 2005 Apr 15;53(2):241-8
15818655
Acta Odontol Scand. 2006 Nov;64(6):341-7
17123910
J Am Podiatr Med Assoc. 1994 Jul;84(7):348-54
8064597
Ann Rheum Dis. 2005 Jan;64(1):99-104
15608306
J Occup Rehabil. 2005 Jun;15(2):167-76
15844674
Cochrane Database Syst Rev. 2003;(4):CD004522
14584019
Am Fam Physician. 2007 Feb 1;75(3):342-8
17304865
J Rheumatol. 2006 May;33(5):939-45
16652424
Disabil Rehabil. 2007 Sep 15;29(17):1331-9
17729081
Clin Orthop Relat Res. 2009 Jun;467(6):1468-75
19283437
Curr Opin Rheumatol. 2009 Mar;21(2):183-8
19339931
J Rheumatol Suppl. 1995 Feb;43:19-22
7752126